These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 3196380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K, Hidaka T, Inomata N, Hamasaki S, Ishihara T, Morita M.
    Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
    [Abstract] [Full Text] [Related]

  • 4. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 3rd communication: effect on cardiovascular system.
    Aisaka K, Hidaka T, Hattori Y, Inomata N, Ishihara T, Satoh F.
    Arzneimittelforschung; 1988 Oct; 38(10):1417-25. PubMed ID: 3196382
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H, Watanabe T, Mori M.
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. General pharmacology of the new quinolone antibacterial agent levofloxacin.
    Takasuna K, Kasai Y, Usui C, Takahashi M, Hirohashi M, Tamura K, Takayama S.
    Arzneimittelforschung; 1992 Mar; 43(3A):408-18. PubMed ID: 1622443
    [Abstract] [Full Text] [Related]

  • 13. General pharmacology of the new antimuscarinic compound vamicamide.
    Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K.
    Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. III: Effects on the central nervous system, striated muscle and carbohydrate and lipid metabolism.
    Osada E, Sakaya S, Sanai K, Seri K.
    Arzneimittelforschung; 1984 Dec; 34(11A):1652-8. PubMed ID: 6152158
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. General pharmacological properties of the main metabolite of flosequinan.
    Fujita S, Ikezono K, Umezato M, Hosoki E, Toba Y, Ishikawa M, Kusunoki A, Shintani S.
    Arzneimittelforschung; 1992 Oct; 42(10):1212-22. PubMed ID: 1335257
    [Abstract] [Full Text] [Related]

  • 18. General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.
    Arisawa H, Imai E, Fujise N, Fukui K, Masunaga H.
    Arzneimittelforschung; 2002 Oct; 52(1):14-20. PubMed ID: 11838269
    [Abstract] [Full Text] [Related]

  • 19. General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.
    Saito T, Fukuda T, Sukamoto T, Yoshidomi M, Morimoto Y, Shimohara K, Ito K.
    Arzneimittelforschung; 1988 Jan; 38(1):66-9. PubMed ID: 2896509
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part II: Central and peripheral nervous systems.
    Hirohashi M, Takasuna K, Kasai Y, Usui C, Kojima H.
    Arzneimittelforschung; 1991 Jan; 41(1):19-24. PubMed ID: 1675569
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.